课题基金 / 基金详情

Phenotypic and Functional Characterization of Relapse-Fated Cells Present at Diagnosis in AML leading to improved therapeutic targeting and monitoring

Phenotypic and Functional Characterization of Relapse-Fated Cells Present at Diagnosis in AML leading to improved therapeutic targeting and monitoring
AML 诊断时存在的复发性细胞的表型和功能特征可改善治疗靶向和监测
批准号：
489132
负责人：
Dick John E
金额：
$76.63万
依托单位：
University Health Network (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-09-01 至 2028-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=489132&lang=en
关键词：
Acute Myeloid Leukemia Biomarker Development Early Detection And Monitoring Leukemic Stem Cells Pharmacogenomics Relapse-Origin Therapeutic Targeting Xenograft Functional Validation

项目摘要

项目成果

Dick John E的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Acute Myeloid Leukemia (AML) has a dismal prognosis and although most patients respond to initial treatment, the majority will relapse with a more resistant disease. Over the past decades, our team has revolutionized the study of AML. Through combined gen
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CIHR Gold Leaf Prize for Discovery
CRC Tier 1
  • 批准号：
    364786
  • 项目类别：
  • 资助金额：
    $101.99万
  • 财政年份：
    2016
  • 负责人：
    Dick John E
  • 依托单位：
    University of Toronto
Regulation of stem cell mediated host immunity by the sphingolipid pathway
  • 批准号：
    344163
  • 项目类别：
    Operating Grants
  • 资助金额：
    $0.0万
  • 财政年份：
    2016
  • 负责人：
    Dick John E
  • 依托单位：
    University Health Network (Toronto)
Identification and Characterization of Human Hematopoietic and Leukemia Stem Cells and Elucidation of their Role in Regenerative Medicine and Disease
  • 批准号：
    355046
  • 项目类别：
    Operating Grants
  • 资助金额：
    $188.5万
  • 财政年份：
    2016
  • 负责人：
    Dick John E
  • 依托单位：
    University Health Network (Toronto)
海外基金